EFFECTS OF DIPYRAMIDOLE AND PROSTAGLANDIN-E1 ON PLASMA-LEVELS OF TISSUE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN CARDIAC PATIENTS

被引：0
|
作者：
HUBER, K
BECKMANN, R
PACHER, R
RIMPFL, T
WOITA, J
BINDER, BR
机构：
[1] UNIV VIENNA,CLIN EXPT PHYSIOL LAB,A-1010 VIENNA,AUSTRIA
[2] UNIV VIENNA,DEPT CARDIOL,A-1010 VIENNA,AUSTRIA
来源：
THROMBOSIS AND HAEMOSTASIS | 1991年 / 65卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1365 / 1365
页数：1
相关论文
共 50 条
  • [31] INTERACTION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 ON THE SURFACE OF ENDOTHELIAL-CELLS
    SAKATA, Y
    OKADA, M
    NORO, A
    MATSUDA, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (04) : 1960 - 1969
  • [32] KINETIC-ANALYSIS OF THE INTERACTION BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    MASSON, C
    ANGLESCANO, E
    [J]. BIOCHEMICAL JOURNAL, 1988, 256 (01) : 237 - 244
  • [33] SYNERGISTIC DISAGGREGATION OF PLATELETS BY TISSUE PLASMINOGEN-ACTIVATOR, PROSTAGLANDIN-E1, AND NITROGLYCERIN
    STAMLER, J
    LOSCALZO, J
    [J]. CLINICAL RESEARCH, 1988, 36 (03): : A420 - A420
  • [34] TGF-BETA INCREASES BOTH UROKINASE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    IWASA, M
    HASHIMOTO, K
    MATSUMOTO, K
    HIGASHIYAMA, M
    HASHIRO, M
    UEDA, K
    KIM, K
    NISHIDA, Y
    TAGO, H
    YOSHIKAWA, K
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (03) : 451 - 451
  • [35] HUMAN PLASMINOGEN-ACTIVATOR INHIBITOR-1 DEFICIENCY
    FAY, WP
    SHAPIRO, AD
    SHIH, JL
    SCHLEEF, RR
    GINSBURG, D
    [J]. CIRCULATION, 1992, 86 (04) : S12 - S12
  • [36] TGF-BETA INCREASES BOTH UROKINASE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    IWASA, M
    HASHIMOTO, K
    MATSUMOTO, K
    HIGASHIYAMA, M
    HASHIRO, M
    UEDA, K
    KIM, K
    NISHIDA, Y
    TAGO, H
    YOSHIKAWA, K
    [J]. CLINICAL RESEARCH, 1989, 37 (02): : A635 - A635
  • [37] EFFECTS OF LOVASTATIN THERAPY ON PLASMINOGEN-ACTIVATOR INHIBITOR-1 ANTIGEN LEVELS
    ISAACSOHN, JL
    SETARO, JF
    NICHOLAS, C
    DAVEY, JA
    DIOTALEVI, LJ
    CHRISTIANSON, DS
    LISKOV, E
    STEIN, EA
    BLACK, HR
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (07): : 735 - 737
  • [38] THE PHARMACOKINETICS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN THE RABBIT
    MAYER, EJ
    FUJITA, T
    GARDELL, SJ
    SHEBUSKI, RJ
    REILLY, CF
    [J]. BLOOD, 1990, 76 (08) : 1514 - 1520
  • [39] TISSUE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR IN PATIENTS WITH LIVER-CIRRHOSIS
    LASIERRA, J
    AZA, MJ
    VILADES, E
    POBLET, S
    BARRAO, F
    BAYON, E
    GONZALEZ, J
    [J]. FIBRINOLYSIS, 1991, 5 (02) : 117 - 120
  • [40] DETERMINANTS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY IN TREATED NIDDM AND ITS RELATION TO A POLYMORPHISM IN THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE
    PANAHLOO, A
    MOHAMEDALI, V
    LANE, A
    GREEN, F
    HUMPHRIES, SE
    YUDKIN, JS
    [J]. DIABETES, 1995, 44 (01) : 37 - 42
12345